Similar articles

• Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?-Reply.

  Ramaswamy VV, Roehr CC. Ramaswamy VV, et al. JAMA Pediatr. 2021 Oct 1;175(10):1079-1080. doi: 10.1001/jamapediatrics.2021.1861. JAMA Pediatr. 2021. PMID: 34228118 No abstract available.
• Is a New Era Coming for Bronchopulmonary Dysplasia Prevention With Corticosteroids?

  Bonadies L, Nardo D, Baraldi E. Bonadies L, et al. JAMA Pediatr. 2021 Oct 1;175(10):1079. doi: 10.1001/jamapediatrics.2021.1858. JAMA Pediatr. 2021. PMID: 34228111 No abstract available.
• Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?

  Doyle LW, Cheong JLY. Doyle LW, et al. Semin Fetal Neonatal Med. 2017 Oct;22(5):290-295. doi: 10.1016/j.siny.2017.07.003. Epub 2017 Jul 19. Semin Fetal Neonatal Med. 2017. PMID: 28734731 Review.
• Commentary on "Early (<7 Days) Systemic Postnatal Corticosteroids for Prevention of Bronchopulmonary Dysplasia in Preterm Infants".

  Bamat NA, Soll RF. Bamat NA, et al. Neonatology. 2023;120(6):805-811. doi: 10.1159/000532079. Epub 2023 Sep 12. Neonatology. 2023. PMID: 37699378 No abstract available.
• Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby.

  Rostas SE, McPherson C. Rostas SE, et al. Neonatal Netw. 2016;35(4):234-9. doi: 10.1891/0730-0832.35.4.234. Neonatal Netw. 2016. PMID: 27461202 Review.